Treato Expands US Presence and Leadership Team with New Senior Executive Hires
Healthcare Industry Veterans, Ezra Ernst and Gerhard Gallwitz, Join Treato Management Team to Accelerate Company US Growth
YEHUD, Israel, October 2, 2013 /PRNewswire/ — Treato, the source of “patient voice” intelligence from across the social web, today announced the appointment of healthcare industry veterans, Ezra Ernst and Gerhard Gallwitz, to its management team as Chief Commercial Officer and Senior Vice President, Product Strategy and Alliances, respectively.
Ernst’s health industry career includes senior executive positions at UnitedHealthcare Group and most recently, Medscape, where he served as Senior Vice President, General Manager of the company’s CME unit. Medscape is a division of WebMD and a leading portal reaching over 2 million health care providers monthly.
“I am excited to be joining Treato at this critical juncture in the evolution of healthcare,” said Ernst. “Patient involvement and engagement is the next major step for the industry. With the insights afforded by Big Data, patients can now be represented in force to address some of healthcare’s most critical challenges. This transparency can lead to to innovation in all areas from new compounds and approaches to treatment to new policies. That is the power of the patient and the power of Treato.”
Gallwitz brings two decades of experience in the life sciences, technology and services sectors, including senior positions at IMS Health and Wyeth Pharmaceuticals (now Pfizer). Prior to joining Treato, Gerhard was Vice President, Product Management & Analytics at Epocrates (EPOC, acquired by athenahealth).
“Joining Treato is an opportunity to be a part of something completely unprecedented in healthcare,” said Gallwitz, “Treato sits at the crossroads of social media, technology, and healthcare delivery and outcomes, providing newfound understanding about what is, and what is not, working throughout the patient journey. This kind of insight holds the potential to benefit all aspects of healthcare including disease state options and pathways, treatment decisions and overall patient care adherence.”
“We are very pleased to welcome Ezra and Gerhard onboard. Both bring significant industry experience and a ‘get-it-done’ attitude that works well with Treato’s entrepreneurial spirit,” said Ido Hadari, CEO of Treato. “We look forward to benefiting from their market savvy and leadership as we continue to expand Treato’s customer base and pursue new opportunities for growth.”
Treato is the source for real-time “patient voice” intelligence, collected from billions of patient conversations across the social web. Treato turns these social health experiences into meaningful insights through its free patient website Treato.com and professional Treato Pharma platform designed specifically for the health and life sciences industries.
Treato is privately held and backed by leading funds including Reed Elsevier Ventures, OrbiMed Partners, New Leaf Venture Partners and Western Technology Investments.
Director of International Marketing